Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects – Genetic Engineering News

March 15, 2012 Posted By: Leave a comment
Araclon Biotech is performing clinical studies with more than 400 ... except as specifically required by law. [1] Prevalence data from the study coordinated by Dr. Jesus de Pedro of the Centro Nacional de Epidemiología. [2] Source: Alzheimer's ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>